Where does Nucletron Operations B.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nucletron Operations B.V. ranks #10,414 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nucletron Operations B.V. hold?

Nucletron Operations B.V. holds 30 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Nucletron Operations B.V.'s Innovation Score?

Nucletron Operations B.V. has an Innovation Score of 37.7 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nucletron Operations B.V. focus on?

Nucletron Operations B.V.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 25 patents, ranking #148 of 1,943 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Nucletron Operations B.V.'s patent grant rate increasing or decreasing?

Nucletron Operations B.V.'s recent grant velocity is -41% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Nucletron Operations B.V.'s patents?

Nucletron Operations B.V.'s patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nucletron Operations B.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nucletron Operations B.V.

USPTO PatentsView assignee record - 30 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nucletron ranks #10,414 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 13 technology areas.

#10,414
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.7/100): 16.8
avg claims per patent: -41%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10414 · Foreign Corporation #10,414 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,414/49,997
PHOTO-FINISH Mythic
CPC-FOCUS A61N · 13 areas
INNOV-THIN 37.7/100
CLAIMS-RICH 16.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -41% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mythic, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nucletron’s 37.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (32%) Velocity 3.0 pts (8%) Breadth 12.7 pts (34%) Claim depth 10.1 pts (27%)

Qualcomm Incorporated · highest

85
Beumer Group & KG · near

38
Brain Trust… · near

38
Green Cross · near

38
Nucletron Operations… · this assignee

38
Thermacell Repellents · near

38
3D Lighting… · lowest

7

What this shows Nucletron's Innovation Score is 37.7/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nucletron?

Each dot is one of Nucletron’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nucletron’s own 16.8 claims/patent is ABOVE the 9.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nucletron vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nucletron's grants concentrate

Nucletron Operations B.V. is a focused PatentsView assignee: 13 CPC subclasses with 83.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2017 (7 grants) versus a trough of 1 in 2018. By volume, Nucletron sits between Mythic, Inc. and Nokian Heavy Tyres Ltd.

Nucletron's three-year grant acceleration

Nucletron Operations B.V. shows 4 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mythic

30
National Institut…

30
Nippon Closures

30
Noven Pharmaceuti…

30
Neumodx Molecular

30
Nevis Industries

30
No Longer Naked L…

30
Nokian Heavy Tyres

30
Nucletron Operati… ◀

30

What this shows Nucletron holds 30 patents at rank #10,409, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nucletron

By rank, the assignees closest to #10,409 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Nucletron's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nucletron, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Nucletron ranks #148 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Brain Trust Innovations I, LLC 38 Beumer Group GMBH & Co. KG 38 Thermacell Repellents, Inc. 38 Green Cross Corporation 38

Nucletron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Nucletron Operations B.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	6.7%
2016	4	13.3%
2017	7	23.3%
2018	1	3.3%
2019	3	10.0%
2020	4	13.3%
2021	2	6.7%
2022	3	10.0%
2024	1	3.3%
2025partial year	3	10.0%

Which technologies does Nucletron Operations B.V. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 25

A61B - DIAGNOSIS; SURGERY; Identification 14

G01T - Measurement OF Nuclear OR X-radiation 3

H05G - X-ray Technique 2

G06T - Image Data Processing OR Generation, IN General 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nucletron Operations B.V.'s patent record in context - here's where to go next.

Nucletron Operations B.V.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 83.3% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #10,414 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nucletron Operations B.V. against Mythic, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.